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Cocaine s stimulant 
and addictive effects 
explained. 
See page 2. 
What Is Cocaine? 
Cocaine is a powerfully addictive stimulant that directly affects the brain. Cocaine was labeled the drug of the 1980s and 1990s because of its extensive 
Cocaine abuse and addiction continue 
to plague our Nation. Today, about one 
in six Americans (15 percent in 2007) 
has tried cocaine by the age of 30, and 7 
percent have tried it by their senior year 
of high school. But recent discoveries 
about the inner workings of the brain 
and the damaging effects of cocaine 
offer us unprecedented opportunities 
for addressing this persistent public 
health problem. 
Genetic studies are providing critical 
information about the hereditary 
influences on the risk of addiction to 
psychoactive substances, including 
cocaine. Moreover, sophisticated imag­
ing technologies have allowed scien­
tists to visualize the brain changes that 
result from chronic drug exposure or 
that happen when an addicted person 
is exposed to drug­associated “cues” 
that can trigger craving and lead to 
relapse. By mapping the genetic factors 
and brain regions responsible for the 
multiple effects of cocaine, these new 
technologies can help us identify new 
targets for treating cocaine addiction. 
NIDA remains vigilant in our quest for 
more effective strategies to address 
the serious public health issues 
linked to cocaine abuse. We not only 
support a wide range of basic and 
clinical research, but also facilitate the 
translation of these research findings 
into real­world settings. To this end, we 
strive to keep the public informed of the 
latest scientific advances in the field of 
addiction. We hope that this compilation 
of scientific information on cocaine 
abuse will inform readers and bolster 
our efforts to tackle the personal and 
social devastation caused by drug 
abuse and addiction. 
Nora D. Volkow, M.D. 
Director 
National Institute on Drug Abuse 
popularity and use during that period. However, cocaine is not 
a new drug. In fact, it is one of the oldest known psychoactive 
substances. Coca leaves, the source of cocaine, have been chewed 
and ingested for thousands of years, and the purified chemical, 
cocaine hydrochloride, has been an abused substance for more 
than 100 years. In the early 1900s, for example, purified cocaine 
was the main active ingredient in most of the tonics and elixirs 
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that were developed to treat a wide 
variety of illnesses. 
Pure cocaine was originally 
extracted from the leaf of the 
Erythroxylon coca bush, which 
grew primarily in Peru and Bolivia. 
After the 1990s, and following crop 
reduction efforts in those countries, 
Colombia became the nation with 
the largest cultivated coca crop. 
Today, cocaine is a Schedule II drug, 
which means that it has high poten­
tial for abuse but can be adminis­
tered by a doctor for legitimate med­
ical uses, such as local anesthesia for 
some eye, ear, and throat surgeries. 
Cocaine is generally sold on the 
street as a fine, white, crystalline 
powder and is also known as “coke,” 
“C,” “snow,” “flake,” or “blow.” 
Street dealers generally dilute it with 
inert substances such as cornstarch, 
talcum powder, or sugar, or with 
Coca bush 
NIDA
Research
Report
Series
2 
active drugs such as procaine 
(a chemically related local anes­
thetic) or amphetamine (another 
stimulant). Some users combine 
cocaine with heroin—in what is 
termed a “speedball.” 
There are two chemical forms 
of cocaine that are abused: the 
water­soluble hydrochloride salt 
and the water­insoluble cocaine 
base (or freebase). When abused, 
the hydrochloride salt, or powdered 
form of cocaine, can be injected or 
snorted. The base form of cocaine 
has been processed with ammonia 
or sodium bicarbonate (baking 
soda) and water, and then heated 
to remove the hydrochloride to 
produce a smokable substance. The 
term “crack,” which is the street 
name given to freebase cocaine, 
refers to the crackling sound heard 
when the mixture is smoked. 
How Is Cocaine 
Abused? 
The principal routes of cocaine 
administration are oral, intranasal, 
intravenous, and inhalation. Snort­
ing, or intranasal administration, 
is the process of inhaling cocaine 
powder through the nostrils, where 
it is absorbed into the bloodstream 
through the nasal tissues. The drug 
also can be rubbed onto mucous 
tissues. Injecting, or intravenous 
use, releases the drug directly into 
the bloodstream and heightens the 
intensity of its effects. Smoking 
involves inhaling cocaine vapor 
or smoke into the lungs, where 
absorption into the bloodstream is 
as rapid as by injection. This rather 
immediate and euphoric effect 
is one of the reasons that crack 
became enormously popular in the 
mid­1980s. 
Cocaine use ranges from occa­
sional to repeated or compulsive use, 
with a variety of patterns between 
these extremes. Other than medi­
cal uses, there is no safe way to use 
cocaine. Any route of administra­
tion can lead to absorption of toxic 
amounts of cocaine, possible acute 
cardiovascular or cerebrovascular 
emergencies, and seizures—all of 
which can result in sudden death. 
How Does 
Cocaine Produce 
Its Effects? 
Research has led to a clear under­
standing of how cocaine produces 
its pleasurable effects and why it 
is so addictive. Scientists have dis­
covered regions within the brain 
that are stimulated by all types of 
reinforcing stimuli such as food, 
sex, and many drugs of abuse. One 
neural system that appears to be 
most affected by cocaine originates 
in a region of the midbrain called 
the ventral tegmental area (VTA). 
Nerve fibers originating in the 
VTA extend to a region known as 
the nucleus accumbens, one of the 
brain’s key areas involved in reward. 
Animal studies show that rewards 
increase levels of the brain chemi­
cal (or neurotransmitter) dopamine, 
thereby increasing neural activity 
in the nucleus accumbens. In the 
normal communication process, 
dopamine is released by a neuron 
into the synapse (the small gap 
between two neurons), where it 
binds to specialized proteins (called 
dopamine receptors) on the neigh­
boring neuron and sends a signal 
Powdered cocaine Freebase cocaine 
to that neuron. Dopamine is then 
removed from the synapse to be 
recycled for further use. Drugs of 
abuse can interfere with this normal 
communication process. For exam­
ple, scientists have discovered that 
cocaine acts by blocking the removal 
of dopamine from the synapse, 
which results in an accumulation of 
dopamine and an amplified signal 
to the receiving neurons (see image 
on page 4, “Cocaine in the brain”). 
This is what causes the initial 
euphoria commonly reported by 
cocaine abusers. 
What Are the 
Short-Term 
Effects of 
Cocaine Use? 
Cocaine’s effects appear almost 
immediately after a single dose 
and disappear within a few min­
utes or within an hour. Taken in 
small amounts, cocaine usually 
makes the user feel euphoric, 
energetic, talkative, and mentally 
alert, especially to the sensations 
of  sight, sound, and touch. It 
can also temporarily decrease 
the need for food and sleep. Some 
users find that the drug helps them 
perform simple physical and 
intellectual tasks more quickly, 
although others experience the 
opposite effect. 
The duration of cocaine’s 
euphoric effect depends upon 
the route of  administration. The 
Source: University of Michigan, 2008 Monitoring the Future Survey. 
What Is the Scope 
of Cocaine Use in 
the United States? 
The National Survey on Drug Use 
and Health (NSDUH) estimates 
that in 2007 there were 2.1 mil­
lion current (past­month) cocaine 
users, of which approximately 
610,000 were current crack users. 
Adults aged 18 to 25 years have a 
higher rate of current cocaine use 
than any other age group, with 1.7 
percent of young adults reporting 
past month cocaine use. Overall, 
men report higher rates of current 
cocaine use than women. Ethnic/ 
racial differences also occur—with 
the highest rates in those reporting 
two or more races (1.1 percent), 
followed by Hispanics (1.0 percent), 
Whites (0.9 percent), and African­
Americans (0.8 percent). 
The 2008 Monitoring the Future 
survey, which annually surveys teen 
attitudes and drug use, reports that 
while there has been a significant 
decline in the 30­day prevalence of 
powder cocaine use among 8th­, 
10th­, and 12th­graders from its 
peak use in the late 1990s, there 
was no significant change in current 
cocaine use from 2001 to 2008; 
however, crack use declined signifi­
cantly during this timeframe among 
8th­ and 12th­graders. 
Repeated cocaine use can produce 
addiction and other adverse health 
consequences. In 2007, according 
to the NSDUH, nearly 1.6 million 
Americans met Diagnostic and Sta­
tistical Manual of Mental Disorders 
criteria for dependence or abuse 
of cocaine (in any form) in the past 
12 months. Further, data from the 
2005 Drug Abuse Warning Network 
(DAWN) report showed that cocaine 
was involved in 448,481 of the 
total 1,449,154 visits to emergency 
departments for drug misuse or 
abuse. This translates to almost 
one in three drug misuse or abuse 
emergency department visits (31 
percent) that involved cocaine. 
Trends in 30-Day Prevalence of Cocaine Abuse 
Among 8th-, 10th-, and 12th-Graders, 1998–2008 
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faster the drug is absorbed, the 
more intense the resulting high, 
but also the shorter the duration. 
The high from snorting is relative­
ly slow to arrive but may last 15 to 
30 minutes; in contrast, the effects 
from smoking are more immediate 
but may last only 5 to 10 minutes. 
The short­term physiological 
effects of  cocaine include con­
stricted blood vessels; dilated 
pupils; and increased temperature, 
heart rate, and blood pressure. 
Large amounts of cocaine may 
intensify the user’s high but can 
also lead to bizarre, erratic, and 
violent behavior. Some cocaine 
users report feelings of  restless­
ness, irritability, and anxiousness. 
Users may also experience trem­
ors, vertigo, muscle twitches, or 
paranoia. There can also be severe 
medical complications associated 
with cocaine abuse. Some of the 
most frequent are cardiovascular 
effects, including disturbances in 
heart rhythm and heart attacks; 
neurological effects, including 
strokes, seizures, headaches, and 
even coma; and gastrointesti­
nal complications, including 
abdominal pain and nausea. In 
rare instances, sudden death can 
occur on the first use of cocaine or 
unexpectedly thereafter. Cocaine­
related deaths are often a result of 
cardiac arrest or seizures followed 
by respiratory arrest. 
Research has also revealed a 
potentially dangerous interaction 
between cocaine and alcohol. 
In fact, this mixture is the most 
common two­drug combination 
that results in drug­related death. 
Cocaine in the brain—In the normal communication process, dopamine is released 
by a neuron into the synapse, where it can bind to dopamine receptors on neighboring 
neurons. Normally, dopamine is then recycled back into the transmitting neuron by a 
specialized protein called the dopamine transporter. If cocaine is present, it attaches to 
the dopamine transporter and blocks the normal recycling process, resulting in a buildup 
of dopamine in the synapse, which contributes to the pleasurable effects of cocaine. 
What Are the 
Long-Term Effects 
of Cocaine Use? 
Cocaine is a powerfully addictive 
drug. Thus, it is unlikely that an 
individual will be able to reliably 
predict or control the extent to 
which he or she will continue to 
want or use the drug. And, if 
addiction takes hold, the risk for 
relapse is high even following long 
periods of  abstinence. Recent stud­
ies have shown that during periods 
of  abstinence, the memory of  the 
cocaine experience or exposure to 
cues associated with drug use can 
trigger tremendous craving and 
relapse to drug use. 
With repeated exposure to 
cocaine, the brain starts to adapt, 
and the reward pathway becomes 
less sensitive to natural reinforcers 
and to the drug itself. Tolerance 
may develop — this means that 
higher doses and/or more frequent 
use of cocaine is needed to register 
the same level of  pleasure expe­
rienced during initial use. At the 
same time, users can also become 
more sensitive (sensitization) to 
cocaine’s anxiety­producing, 
convulsant, and other toxic effects. 
Users take cocaine in “binges,” 
during which the cocaine is used 
repeatedly and at increasingly 
higher doses. This can lead to 
increased irritability, restlessness, 
and paranoia — even a full­blown 
paranoid psychosis, in which the 
individual loses touch with reality 
and experiences auditory halluci­
nations. With increasing dosages 
or frequency of  use, the risk of 
adverse psychological or physio­
logical effects increases. 
Different routes of cocaine 
administration can produce dif­
ferent adverse effects. Regularly 
snorting cocaine, for example, 
can lead to loss of sense of smell; 
nosebleeds; problems with swal­
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Brain images showing decreased 
dopamine (D2) receptors in the brain 
of a person addicted to cocaine 
versus a non­drug user. The dopamine 
system is important for conditioning 
and motivation, and alterations such 
as this are likely responsible, in part, 
for the diminished sensitivity to 
natural rewards that develops 
with addiction. 
lowing; hoarseness; and an overall 
irritation of the nasal septum, 
which could result in a chronically 
inflamed, runny nose. Ingested 
cocaine can cause severe bowel 
gangrene, due to reduced blood 
flow. Persons who inject cocaine 
have puncture marks called 
“tracks,” most commonly in their 
forearms, and may experience 
allergic reactions, either to the 
drug or to some additive in street 
cocaine, which in severe cases can 
result in death. Many chronic 
cocaine users lose their appetite 
and experience significant weight 
loss and malnourishment. 
Are Cocaine 
Abusers at Risk 
for Contracting 
HIV/AIDS and 
Hepatitis? 
Yes, cocaine abusers are at increased 
risk for contracting such infectious 
diseases as human immunodeficien­
cy virus/acquired immune deficiency 
syndrome (HIV/AIDS) and viral 
hepatitis. This risk stems not only 
from sharing contaminated needles 
and drug paraphernalia but also 
from engaging in risky behaviors as 
a result of intoxication. Research 
has shown that drug intoxication 
and addiction can compromise 
judgment and decisionmaking, 
and potentially lead to risky sexual 
encounters, needle sharing, and 
trading sex for drugs—by both men 
and women. In fact, some studies 
are showing that among drug abus­
ers, those who do not inject drugs 
are contracting HIV at rates equal 
to those who do inject drugs, further 
highlighting the role of sexual trans­
mission of HIV in this population. 
Additionally, hepatitis C (HCV) 
has spread rapidly among injecting 
drug users. Nearly 50 percent are 
exposed within 2 years of initiating 
injection drug use, and infection 
rates are between 40 and 98 percent 
in those injecting for more than 2 
years. Although treatment for HCV 
is not effective for everyone and can 
have significant side effects, medi­
cal followup is essential for all those 
who are infected. There is no vac­
cine for the hepatitis C virus, and it 
is highly transmissible via injection; 
thus, HCV testing is recommended 
for any individual who has ever 
injected drugs. 
What Treatments 
Are Effective for 
Cocaine Abusers? 
In 2006, cocaine accounted for 
about 14 percent of all admissions 
to drug abuse treatment programs. 
The majority of individuals (71 
percent in 2006) who seek treatment 
for cocaine abuse smoke crack and 
are likely to be polydrug abusers, or 
users of more than one substance. 
The widespread abuse of cocaine 
has stimulated extensive efforts to 
develop treatment programs for 
cocaine. As with any drug addic­
tion, this is a complex disease that 
involves biological changes in the 
brain as well as myriad social, 
familial, and other environmental 
problems. Therefore, treatment of 
cocaine addiction must be compre­
hensive, and strategies need to assess 
the neurobiological, social, and 
medical aspects of the patient’s drug 
abuse. Moreover, patients who have 
a variety of addictions often have 
other co­occurring mental disorders 
that require additional behavioral or 
pharmacological interventions. 
Pharmacological Approaches 
Presently, there are no FDA­
approved medications to treat 
cocaine addiction. Consequently, 
NIDA is aggressively working to 
identify and test new medications 
to treat cocaine addiction safely 
and effectively. Several medications 
marketed for other diseases (e.g., 
baclofen, modafinil, tiagabine, disul­
firam, and topiramate) show prom­
ise and have been reported to reduce 
cocaine use in controlled clinical 
trials. Among these, disulfiram (used 
to treat alcoholism) has produced 
the most consistent reductions in 
cocaine abuse. On the other hand, 
new knowledge of how the brain 
is changed by cocaine is directing 
attention to novel targets for medi­
cations development. Compounds 
that are currently being tested for 
addiction treatment take advantage 
of underlying cocaine­induced 
adaptations in the brain that disturb 
the balance between excitatory 
(glutamate) and inhibitory (gamma­
aminobutyric acid) neurotransmis­
sion. Also, dopamine D3 receptors 
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What Are 
the Effects 
of Maternal 
Cocaine Use? 
The full extent of the effects of 
prenatal cocaine exposure on a child 
are not completely known, but many 
scientific studies have documented 
that babies born to mothers who 
abuse cocaine during pregnancy are 
often prematurely delivered, have 
low birthweights and smaller head 
circumferences, and are shorter in 
length than babies born to mothers 
who do not abuse cocaine. 
Nevertheless, it is difficult to esti­
mate the full extent of the conse­
quences of maternal drug abuse and 
to determine the specific hazard of 
a particular drug to the unborn child. 
This is because multiple factors— 
such as the amount and number of 
all drugs abused, including nicotine; 
extent of prenatal care; possible 
neglect or abuse of the child; expo­
sure to violence in the environment; 
socioeconomic conditions; maternal 
nutrition; other health conditions; 
and exposure to sexually transmitted 
diseases—can all interact to impact 
maternal, fetal, and child outcomes. 
Some may recall that “crack babies,” 
or babies born to mothers who 
abused crack cocaine while preg­
nant, were at one time written off 
as a lost generation. They were 
predicted to suffer from severe, irre­
versible damage, including reduced 
intelligence and social skills. It was 
later found that this was a gross 
exaggeration. However, the fact that 
most of these children appear nor­
mal should not be overinterpreted 
to indicate that there is no cause 
for concern. Using sophisticated 
technologies, scientists are now 
finding that exposure to cocaine dur­
ing fetal development may lead to 
subtle, yet significant, later deficits 
in some children, including deficits in 
some aspects of cognitive perfor­
mance, information processing, and 
attention to tasks—abilities that are 
important for the realization of a 
child’s full potential. 
(a subtype of dopamine receptor) 
constitute a novel molecular target 
of high interest. Medications that 
act at these receptors are just now 
being tested for safety in humans. 
Finally, a cocaine vaccine that pre­
vents entry of cocaine into the brain 
holds great promise for reducing 
the risk of relapse. In addition to 
treatments for addiction, medical 
treatments are being developed to 
address the acute emergencies that 
result from cocaine overdose 
each year. 
Behavioral Interventions 
Many behavioral treatments for 
cocaine addiction have proven to be 
effective in both residential and out­
patient settings. Indeed, behavioral 
therapies are often the only available 
and effective treatments for many 
drug problems, including stimulant 
addictions. However, the integration 
of behavioral and pharmacological 
treatments may ultimately prove to 
be the most effective approach. 
One form of behavioral therapy 
that is showing positive results in 
Presently, there 
are no proven 
medications to treat 
cocaine addiction. 
Consequently, NIDA 
is aggressively 
working to identify 
and test new 
medications. 
cocaine­addicted populations is 
contingency management, or moti­
vational incentives (MI). MI may 
be particularly useful for helping 
patients achieve initial abstinence 
from cocaine and for helping 
patients stay in treatment. Programs 
use a voucher or prize­based system 
that rewards patients who abstain 
from cocaine and other drug use. 
On the basis of drug­free urine 
tests, the patients earn points, or 
chips, which can be exchanged for 
items that encourage healthy living, 
such as joining a gym or going to a 
movie or dinner. This approach has 
recently been shown to be practical 
and effective in community treat­
ment programs. 
Cognitive­behavioral therapy 
(CBT) is an effective approach for 
preventing relapse. CBT is focused 
on helping cocaine­addicted indi­
viduals abstain  and remain 
abstinent from cocaine and other 
substances. The underlying assump­
tion is that learning processes play 
an important role in the develop­
ment and continuation of cocaine 
abuse and addiction. These same 
learning processes can be harnessed 
to help individuals reduce drug use 
and successfully prevent relapse. 
This approach attempts to help 
patients recognize, avoid, and cope; 
that is, they recognize the situations 
in which they are most likely to use 
cocaine, avoid these situations when 
appropriate, and cope more effec­
tively with a range of problems and 
problematic behaviors associated 
with drug abuse. This therapy is also 
noteworthy because of its compat­
ibility with a range of other treat­
ments patients may receive, includ­
ing pharmacotherapy. 
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Therapeutic communities and focus on successful reinsertion It is important that patients 
(TCs), or residential programs, of the individual into society. receive services that match all of 
offer another alternative to persons Community­based recovery their treatment needs. For example, 
in need of treatment for cocaine groups—such as Cocaine Anony­ if a patient is unemployed, it may 
addiction. TCs usually require a mous—which use a 12­step program, be helpful to provide vocational 
6­ or 12­month stay and use the pro­ can also be helpful to people trying rehabilitation or career counseling 
gram’s entire “community” as active to sustain abstinence. Participants along with addiction treatment. If 
components of treatment. They can may benefit from supportive fellow­ a patient has marital problems, it 
include onsite vocational rehabilita­ ship and sharing with those experi­ may be important to offer couples 
tion and other supportive services encing common problems and issues. counseling. 
continued on page 8 
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Glossary 
Addiction: A chronic, relaps­
ing disease characterized by 
compulsive drug seeking and 
use and by neurochemical and 
molecular changes in the brain. 
Anesthetic: An agent that 
causes insensitivity to pain. 
Coca: The plant, Erythroxylon, 
from which cocaine is derived. 
Also refers to the leaves of 
this plant. 
Cocaethylene: A potent stimu­
lant formed in the body when 
cocaine and alcohol are used 
together. 
Crack: The slang term for a 
smokable form of cocaine. 
Craving: A powerful, often 
uncontrollable, desire for drugs. 
Dopamine: A neurotransmitter 
present in regions of the brain 
that regulate movement, emo­
tion, motivation, and the feeling 
of pleasure. 
Freebase: A solid, water­
insoluble, and smokable form 
of cocaine that is produced 
when its hydrochloride salt form 
is processed with ammonia 
or sodium bicarbonate, and 
water, then heated to remove 
the hydrochloride. (Also, see 
“crack.”) 
Frontal cortex: The front part of 
the brain involved with reason­
ing, planning, problemsolving, 
and other higher cognitive 
functions. 
Gamma-aminobutyric acid 
(GABA): The main inhibitory 
neurotransmitter in the central 
nervous system. GABA provides 
the needed counterbalance to 
the actions of other systems, 
particularly the excitatory neu­
rotransmitter glutamate. 
Glutamate: An excitatory 
neurotransmitter found through­
out the brain, that influences 
the reward system and is 
involved in learning and memory 
among other functions. 
Hydrochloride salt: A pow­
dered, water­soluble form of 
cocaine that can be injected 
or snorted. 
Neuron: A nerve cell. 
Nucleus accumbens: A brain 
region involved in motivation 
and reward. Nearly all drugs 
of abuse directly or indirectly 
increase dopamine in the 
nucleus accumbens, contribut­
ing to their addictive properties. 
Physical dependence: A state 
in which the body adapts to 
a drug and where withdrawal 
occurs if use of the drug is 
stopped abruptly. Physical 
dependence can happen 
with chronic—even appropri­
ate—use of many drugs, 
and in and of itself does not 
constitute addiction. 
Polydrug user: An individual 
who uses more than one drug. 
Rush: A surge of pleasure that 
rapidly follows administration 
of some drugs. 
Stimulant: A class of drugs that 
increase or enhance the activity 
of monamines (such as dop­
amine) in the brain. Stimulants 
increase arousal, heart rate, 
blood pressure, and respiration, 
and decrease appetite. Includes 
some medications used to treat 
attention­deficit hyperactivity 
disorder (e.g., methylphenidate 
and amphetamines), as well as 
cocaine and methamphetamine. 
Tolerance: A condition in which 
higher doses of a drug are 
required to produce the same 
effect as during initial use. 
Vertigo: The sensation 
of dizziness. 
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Where Can I Get More Scientific Information 
About Cocaine Abuse and Addiction? 
To learn more about cocaine and 
other drugs of abuse, or to order 
materials on these topics free 
of charge in English or Spanish, 
visit the NIDA Web site at 
www.drugabuse.gov 
or contact the DrugPubs Research 
Dissemination Center at 
877­NIDA­NIH (877­643­2644; 
TTY/TDD: 240­645­0228). 
What’s New on the NIDA Web Site 
•	 Information	on	drugs	of	abuse
•	 Publications	and	communications	
(including NIDA Notes and 
Addiction Science & Clinical 
Practice journal) 
•	 Calendar	of	events
•	 Links	to	NIDA	organizational	
units 
•	 Funding	information	(including	
program announcements and 
deadlines) 
•	 International	activities
•	 Links	to	related	Web	sites	
(access to Web sites of many 
other organizations in the field) 
NIDA Web Sites 
drugabuse.gov 
backtoschool.drugabuse.gov 
teens.drugabuse.gov 
For Physician Information 
www.drugabuse.gov/nidamed 
Other Web Sites 
Information on cocaine abuse and 
addiction is also available through 
the following Web site: 
•	 Substance	Abuse	and	Mental	
Health Services Administration 
Health Information Network: 
www.samhsa.gov/shin 
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